메뉴 건너뛰기
Current Hepatitis Reports
Volumn 8, Issue 4, 2009, Pages 154-160
Current treatment of chronic HBV infection: An Asian-Pacific perspective
Author keywords

[No Author keywords available]
Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; PEGINTERFERON ALPHA2A; PLACEBO; TELBIVUDINE; TENOFOVIR; THYMOSIN ALPHA1; VIRUS DNA;
EID: 70449513410     PISSN: 15403416     EISSN: 15410706     Source Type: Journal    
DOI: 10.1007/s11901-009-0022-x     Document Type: Review
Times cited : (2)
References (55)
  • 1
    • 59749096640 scopus 로고    scopus 로고
    • Hepatitis B virus infection
    • 10.1016/S0140-6736(09)60207-5 1:CAS:528:DC%2BD1MXhvFGltLk%3D 19217993
    • Y.F. Liaw C.M. Chu 2009 Hepatitis B virus infection Lancet 373 582 592 10.1016/S0140-6736(09)60207-5 1:CAS:528:DC%2BD1MXhvFGltLk%3D 19217993
    • (2009) Lancet , vol.373 , pp. 582-592
    • Liaw, Y.F.1    Chu, C.M.2
  • 2
    • 38049044476 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors
    • 10.1016/j.jhep.2007.11.011 18096267
    • G. Fattovich F. Bortolotti F. Donato 2008 Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors J Hepatol 48 335 352 10.1016/j.jhep.2007.11.011 18096267
    • (2008) J Hepatol , vol.48 , pp. 335-352
    • Fattovich, G.1    Bortolotti, F.2    Donato, F.3
  • 3
    • 59149086601 scopus 로고    scopus 로고
    • Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
    • 10.1111/j.1478-3231.2008.01941.x 19207972
    • Y.F. Liaw 2009 Natural history of chronic hepatitis B virus infection and long-term outcome under treatment Liver Int 29 Suppl1 100 107 10.1111/j.1478-3231.2008.01941.x 19207972
    • (2009) Liver Int , vol.29 , Issue.SUPPL. 1 , pp. 100-107
    • Liaw, Y.F.1
  • 4
    • 40849105240 scopus 로고    scopus 로고
    • Hepatitis B: Reflection on the current approach to antiviral therapy
    • 10.1016/j.jhep.2008.01.011 1:CAS:528:DC%2BD1cXjtlelsL8%3D 18304680
    • F. Zoulim R. Perrillo 2008 Hepatitis B: reflection on the current approach to antiviral therapy J Hepatol 48 S2 S19 10.1016/j.jhep.2008.01.011 1:CAS:528:DC%2BD1cXjtlelsL8%3D 18304680
    • (2008) J Hepatol , vol.48
    • Zoulim, F.1    Perrillo, R.2
  • 5
    • 33847701354 scopus 로고    scopus 로고
    • Chronic hepatitis B
    • DOI 10.1002/hep.21513
    • A.S. Lok B.J. McMahon 2007 Chronic hepatitis B Hepatology 45 507 539 10.1002/hep.21513 1:CAS:528:DC%2BD2sXisVKns7o%3D 17256718 (Pubitemid 46374607)
    • (2007) Hepatology , vol.45 , Issue.2 , pp. 507-539
    • Lok, A.S.F.1    McMahon, B.J.2
  • 6
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
    • 10.1007/s12072-008-9080-3 19669255
    • Y.F. Liaw N. Leung J.H. Kao, et al. 2008 Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 263 283 10.1007/s12072-008-9080-3 19669255
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.F.1    Leung, N.2    Kao, J.H.3
  • 7
    • 58149296156 scopus 로고    scopus 로고
    • EASL clinical practice guidelines: Management of chronic hepatitis B
    • European Association for the Study of the Liver. 10.1016/j.jhep.2008.10. 001 1:STN:280:DC%2BD1M%2FntlOjtA%3D%3D 19054588
    • European Association for the Study of the Liver. 2009 EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 227 242 10.1016/j.jhep.2008.10.001 1:STN:280:DC%2BD1M%2FntlOjtA%3D%3D 19054588
    • (2009) J Hepatol , vol.50 , pp. 227-242
  • 9
    • 57149091722 scopus 로고    scopus 로고
    • A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update
    • 10.1016/j.cgh.2008.08.021 1:CAS:528:DC%2BD1MXhtFSlurk%3D 18845489
    • E.B. Keeffe D.T. Dieterich S.H. Han, et al. 2008 A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update Clin Gastroenterol Hepatol 6 1315 1341 10.1016/j.cgh.2008.08.021 1:CAS:528:DC%2BD1MXhtFSlurk%3D 18845489
    • (2008) Clin Gastroenterol Hepatol , vol.6 , pp. 1315-1341
    • Keeffe, E.B.1    Dieterich, D.T.2    Han, S.H.3
  • 10
    • 67649224111 scopus 로고    scopus 로고
    • Antiviral therapies of chronic hepatitis B: Opportunities and challenges in Asia
    • 10.1016/j.jhep.2009.04.003 19467727
    • Y.F. Liaw 2009 Antiviral therapies of chronic hepatitis B: opportunities and challenges in Asia J Hepatol 51 403 410 10.1016/j.jhep.2009.04.003 19467727
    • (2009) J Hepatol , vol.51 , pp. 403-410
    • Liaw, Y.F.1
  • 11
    • 41549102624 scopus 로고    scopus 로고
    • Role of viral factors in the natural course and therapy of chronic hepatitis B
    • 10.1007/s12072-007-9033-2 19669337
    • J.H. Kao 2007 Role of viral factors in the natural course and therapy of chronic hepatitis B Hepatol Int 1 415 430 10.1007/s12072-007-9033-2 19669337
    • (2007) Hepatol Int , vol.1 , pp. 415-430
    • Kao, J.H.1
  • 13
    • 0036614299 scopus 로고    scopus 로고
    • Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
    • DOI 10.1053/jhep.2002.33638
    • Y.S. Hsu R.N. Chien C.T. Yeh, et al. 2002 Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B Hepatology 35 1522 1527 10.1053/jhep.2002.33638 12029639 (Pubitemid 34966908)
    • (2002) Hepatology , vol.35 , Issue.6 , pp. 1522-1527
    • Hsu, Y.-S.1    Chien, R.-N.2    Yeh, C.-T.3    Sheen, I.-S.4    Chiou, H.-Y.5    Chu, C.-M.6    Liaw, Y.-F.7
  • 14
    • 33646368376 scopus 로고    scopus 로고
    • Hepatitis B virus-related cirrhosis: Natural history and treatment
    • DOI 10.1055/s-2006-939752
    • C.M. Chu Y.F. Liaw 2006 Hepatitis B virus-related cirrhosis: natural history and treatment Semin Liver Dis 26 142 152 10.1055/s-2006-939752 1:CAS:528:DC%2BD28Xltlegsr8%3D 16673292 (Pubitemid 43668256)
    • (2006) Seminars in Liver Disease , vol.26 , Issue.2 , pp. 142-152
    • Chu, C.-M.1    Liaw, Y.-F.2
  • 15
    • 35948991840 scopus 로고    scopus 로고
    • Natural course following the onset of cirrhosis in patients with chronic hepatitis B: A long-term follow-up study
    • 10.1007/s12072-007-5001-0 19669348
    • Y.C. Chen C.M. Chu C.T. Yeh Y.F. Liaw 2007 Natural course following the onset of cirrhosis in patients with chronic hepatitis B: a long-term follow-up study Hepatol Int 1 267 273 10.1007/s12072-007-5001-0 19669348
    • (2007) Hepatol Int , vol.1 , pp. 267-273
    • Chen, Y.C.1    Chu, C.M.2    Yeh, C.T.3    Liaw, Y.F.4
  • 17
    • 33644858331 scopus 로고    scopus 로고
    • Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
    • DOI 10.1053/j.gastro.2005.11.016, PII S0016508505022766
    • U.H. Iloeje H.I. Yang J. Su, et al. 2006 Predicting cirrhosis risk based on the level of circulating hepatitis B viral load Gastroenterology 130 678 686 10.1053/j.gastro.2005.11.016 16530509 (Pubitemid 43374518)
    • (2006) Gastroenterology , vol.130 , Issue.3 , pp. 678-686
    • Iloeje, U.H.1    Yang, H.-I.2    Su, J.3    Jen, C.-L.4    You, S.-L.5    Chen, C.-J.6
  • 18
    • 51049117284 scopus 로고    scopus 로고
    • Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma
    • REVEAL-HBV Study Group et al. 10.1093/jnci/djn243 1:CAS:528: DC%2BD1cXhtFKrsb7P 18695135
    • H.I. Yang S.H. Yeh P.J. Chen REVEAL-HBV Study Group, et al. 2008 Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma J Natl Cancer Inst 100 1134 1143 10.1093/jnci/djn243 1:CAS:528:DC%2BD1cXhtFKrsb7P 18695135
    • (2008) J Natl Cancer Inst , vol.100 , pp. 1134-1143
    • Yang, H.I.1    Yeh, S.H.2    Chen, P.J.3
  • 19
    • 33846983919 scopus 로고    scopus 로고
    • Chronic hepatitis B virus infection acquired in childhood: Special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion
    • DOI 10.1111/j.1365-2893.2006.00810.x
    • C.M. Chu Y.F. Liaw 2007 Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion J Viral Hepat 14 147 152 10.1111/j.1365-2893.2006.00810.x 17305879 (Pubitemid 46257187)
    • (2007) Journal of Viral Hepatitis , vol.14 , Issue.3 , pp. 147-152
    • Chu, C.-M.1    Liaw, Y.-F.2
  • 20
    • 33749364107 scopus 로고    scopus 로고
    • Hepatitis B virus replication and liver disease progression: The impact of antiviral therapy
    • 1:CAS:528:DC%2BD28XhtFKgsLvJ 17310811
    • Y.F. Liaw 2006 Hepatitis B virus replication and liver disease progression: The impact of antiviral therapy Antivir Ther 11 669 679 1:CAS:528:DC%2BD28XhtFKgsLvJ 17310811
    • (2006) Antivir Ther , vol.11 , pp. 669-679
    • Liaw, Y.F.1
  • 21
    • 0028347933 scopus 로고
    • Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: A randomised controlled trial
    • 10.1016/S0168-8278(05)80055-8 1:STN:280:DyaK2c3nsFWgsw%3D%3D 8006397
    • Y.F. Liaw S.M. Lin T.J. Chen, et al. 1994 Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomised controlled trial J Hepatol 20 175 180 10.1016/S0168-8278(05)80055-8 1:STN:280:DyaK2c3nsFWgsw%3D%3D 8006397
    • (1994) J Hepatol , vol.20 , pp. 175-180
    • Liaw, Y.F.1    Lin, S.M.2    Chen, T.J.3
  • 22
    • 0026602420 scopus 로고
    • A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
    • 1:STN:280:DyaK383msleitg%3D%3D 1587429
    • A.S. Lok P.C. Wu C.L. Lai, et al. 1992 A controlled trial of interferon with or without prednisone priming for chronic hepatitis B Gastroenterology 102 2091 2097 1:STN:280:DyaK383msleitg%3D%3D 1587429
    • (1992) Gastroenterology , vol.102 , pp. 2091-2097
    • Lok, A.S.1    Wu, P.C.2    Lai, C.L.3
  • 23
    • 32944461658 scopus 로고    scopus 로고
    • Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
    • 16034852
    • M.T. Mellerup K. Krogsgaard P. Mathurin, et al. 2005 Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B Cochrane Database Syst Rev 3 CD000345 16034852
    • (2005) Cochrane Database Syst Rev , vol.3 , pp. 000345
    • Mellerup, M.T.1    Krogsgaard, K.2    Mathurin, P.3
  • 24
    • 0035552878 scopus 로고    scopus 로고
    • Long-term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan
    • DOI 10.1046/j.1365-2893.2001.00320.x
    • C.C. Lin J.C. Wu T.T. Chang, et al. 2001 Long-term evaluation of recombinant interferon alpha2b in the treatment of patients with hepatitis B e antigen-negative chronic hepatitis B in Taiwan J Viral Hepat 8 438 446 10.1046/j.1365-2893.2001.00320.x 1:STN:280:DC%2BD3MnpsVChsg%3D%3D 11703575 (Pubitemid 35013569)
    • (2001) Journal of Viral Hepatitis , vol.8 , Issue.6 , pp. 438-446
    • Lin, C.-C.1    Wu, J.-C.2    Chang, T.-T.3    Huang, Y.-H.4    Wang, Y.-J.5    Tsay, S.-H.6    Chow, N.-H.7    Chang, F.-Y.8    Lee, S.-D.9
  • 25
    • 33751514752 scopus 로고    scopus 로고
    • Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
    • DOI 10.1016/j.jhep.2006.08.021, PII S0168827806005496
    • S.M. Lin M.L. Yu C.M. Lee, et al. 2007 Interferon therapy in HBeAg positive chronic hepatitis reduces cirrhosis and hepatocellular carcinoma J Hepatol 46 45 52 10.1016/j.jhep.2006.08.021 1:CAS:528:DC%2BD28Xht1Krs7vK 17107734 (Pubitemid 44827423)
    • (2007) Journal of Hepatology , vol.46 , Issue.1 , pp. 45-52
    • Lin, S.-M.1    Yu, M.-L.2    Lee, C.-M.3    Chien, R.-N.4    Sheen, I.-S.5    Chu, C.-M.6    Liaw, Y.-F.7
  • 26
    • 0029893146 scopus 로고    scopus 로고
    • Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
    • DOI 10.1056/NEJM199605303342202
    • C. Niederau T. Heintges S. Lange, et al. 1996 Long-term followup of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B N Engl J Med 334 1422 1427 10.1056/NEJM199605303342202 1:STN:280: DyaK283hvVyhtw%3D%3D 8618580 (Pubitemid 26157437)
    • (1996) New England Journal of Medicine , vol.334 , Issue.22 , pp. 1422-1427
    • Niederau, C.1    Heintges, T.2    Lange, S.3    Goldmann, G.4    Niederau, C.M.5    Mohr, L.6    Haussinger, D.7
  • 27
    • 0035110693 scopus 로고    scopus 로고
    • The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B
    • DOI 10.1016/S0168-8278(00)00094-5, PII S0168827800000945
    • G.V. Papatheodoridis E. Manesis S.J. Hadziyannis 2001 The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B J Hepatol 34 306 313 10.1016/S0168-8278(00)00094-5 1:CAS:528:DC%2BD3MXislCksbo%3D 11281561 (Pubitemid 32176454)
    • (2001) Journal of Hepatology , vol.34 , Issue.2 , pp. 306-313
    • Papatheodoridis, G.V.1    Manesis, E.2    Hadziyannis, S.J.3
  • 28
    • 53549107488 scopus 로고    scopus 로고
    • Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
    • 10.1111/j.1365-2036.2008.03816.x 1:STN:280:DC%2BD1cnpt12rtw%3D%3D 18657133
    • J.J. Sung K.K. Tsoi V.W. Wong, et al. 2008 Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 1067 1077 10.1111/j.1365-2036.2008.03816.x 1:STN:280: DC%2BD1cnpt12rtw%3D%3D 18657133
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 1067-1077
    • Sung, J.J.1    Tsoi, K.K.2    Wong, V.W.3
  • 31
    • 51049088452 scopus 로고    scopus 로고
    • Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B
    • DOI 10.1007/s12072-007-9022-5
    • T. Piratvisuth G. Lau Y.C. Chao, et al. 2008 Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B Hepatol Int 2 102 110 10.1007/s12072-007-9022-5 19669285 (Pubitemid 351250409)
    • (2008) Hepatology International , vol.2 , Issue.1 , pp. 102-110
    • Piratvisuth, T.1    Lau, G.2    Chao, Y.-C.3    Jin, R.4    Chutaputti, A.5    Zhang, Q.-B.6    Tanwandee, T.7    Button, P.8    Popescu, M.9
  • 34
    • 2942564440 scopus 로고    scopus 로고
    • Thymalfasin for the treatment of chronic hepatitis B
    • 10.1586/14787210.2.1.9 1:CAS:528:DC%2BD2cXisFCqsL8%3D 15482167
    • R.N. Chien Y.F. Liaw 2004 Thymalfasin for the treatment of chronic hepatitis B Expert Rev Anti-Infect Ther 2 9 16 10.1586/14787210.2.1.9 1:CAS:528:DC%2BD2cXisFCqsL8%3D 15482167
    • (2004) Expert Rev Anti-Infect Ther , vol.2 , pp. 9-16
    • Chien, R.N.1    Liaw, Y.F.2
  • 35
    • 0031596591 scopus 로고    scopus 로고
    • 1 in patients with chronic hepatitis B: A randomized, controlled trial
    • DOI 10.1002/hep.510270527
    • R.N. Chien Y.F. Liaw T.C. Chen, et al. 1998 Efficacy of thymosin alpha-1 in patients with chronic type B hepatitis: a randomized controlled trial Hepatology 27 1383 1387 10.1002/hep.510270527 1:CAS:528:DyaK1cXjtVSjt7g%3D 9581695 (Pubitemid 28227868)
    • (1998) Hepatology , vol.27 , Issue.5 , pp. 1383-1387
    • Chien, R.-N.1    Liaw, Y.-F.2    Chen, T.-C.3    Yeh, C.-T.4    Sheen, I.-S.5
  • 36
    • 0035663014 scopus 로고    scopus 로고
    • The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: A meta-analysis
    • DOI 10.1046/j.1365-2036.2001.01135.x
    • H.L.Y. Chan J.L. Tang W. Tam J.J.Y. Sung 2001 The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a metaanalysis Aliment Pharmacol Ther 15 1899 1905 10.1046/j.1365-2036.2001.01135.x 1:CAS:528:DC%2BD38Xks1Srtg%3D%3D 11736720 (Pubitemid 34014345)
    • (2001) Alimentary Pharmacology and Therapeutics , vol.15 , Issue.12 , pp. 1899-1905
    • Chan, H.L.-Y.1    Tang, J.-L.2    Tam, W.3    Sung, J.J.-Y.4
  • 37
    • 38349056857 scopus 로고    scopus 로고
    • Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: A meta-analysis
    • 10.1016/j.antiviral.2007.10.014 1:CAS:528:DC%2BD1cXotlOlsA%3D%3D 18078676
    • Y.F. Yang W. Zhao Y.D. Zhong, et al. 2008 Comparison of the efficacy of thymosin alpha-1 and interferon alpha in the treatment of chronic hepatitis B: a meta-analysis Antivir Res 77 136 141 10.1016/j.antiviral.2007.10.014 1:CAS:528:DC%2BD1cXotlOlsA%3D%3D 18078676
    • (2008) Antivir Res , vol.77 , pp. 136-141
    • Yang, Y.F.1    Zhao, W.2    Zhong, Y.D.3
  • 42
    • 0033012793 scopus 로고    scopus 로고
    • Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B
    • 10.1002/hep.510290321 1:CAS:528:DyaK1MXhvFyjsLs%3D 10051494
    • N.C. Tassopoulos R. Volpes G. Pastore, et al. 1999 Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B Hepatology 29 889 896 10.1002/hep.510290321 1:CAS:528:DyaK1MXhvFyjsLs%3D 10051494
    • (1999) Hepatology , vol.29 , pp. 889-896
    • Tassopoulos, N.C.1    Volpes, R.2    Pastore, G.3
  • 43
    • 33750942083 scopus 로고    scopus 로고
    • Short term lamivudine therapy in active HBeAg-negative chronic hepatitis B patients in Taiwan
    • 1:CAS:528:DC%2BD28Xhtlajs7vI 17302259
    • R.N. Chien Y.F. Liaw 2006 Short term lamivudine therapy in active HBeAg-negative chronic hepatitis B patients in Taiwan Antivir Ther 11 947 952 1:CAS:528:DC%2BD28Xhtlajs7vI 17302259
    • (2006) Antivir Ther , vol.11 , pp. 947-952
    • Chien, R.N.1    Liaw, Y.F.2
  • 44
    • 0032783679 scopus 로고    scopus 로고
    • Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy
    • DOI 10.1002/hep.510300221
    • Y.F. Liaw R.N. Chien C.T. Yeh, et al. 1999 Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy Hepatology 30 567 572 10.1002/hep.510300221 1:CAS:528:DyaK1MXlt1ajsLg%3D 10421670 (Pubitemid 29357527)
    • (1999) Hepatology , vol.30 , Issue.2 , pp. 567-572
    • Liaw, Y.-F.1    Chien, R.-N.2    Yeh, C.-T.3    Tsai, S.-L.4    Chu, C.-M.5
  • 48
    • 58949102948 scopus 로고    scopus 로고
    • Nucleos(t)ide analogues for hepatitis B virus: Strategies for long-term success
    • 10.1016/j.bpg.2008.11.003 1:CAS:528:DC%2BD1MXhtlOitLc%3D 19187868
    • R.N. Chien Y.F. Liaw 2008 Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success Best Pract Res Clin Gastroenterol 22 1081 1092 10.1016/j.bpg.2008.11.003 1:CAS:528:DC%2BD1MXhtlOitLc%3D 19187868
    • (2008) Best Pract Res Clin Gastroenterol , vol.22 , pp. 1081-1092
    • Chien, R.N.1    Liaw, Y.F.2
  • 49
    • 35648982926 scopus 로고    scopus 로고
    • Low Resistance to Adefovir Combined With Lamivudine: A 3-Year Study of 145 Lamivudine-Resistant Hepatitis B Patients
    • DOI 10.1053/j.gastro.2007.08.079, PII S001650850701640X
    • P. Lampertico M. Viganò E. Manenti, et al. 2007 Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients Gastroenterology 133 1445 1451 10.1053/j.gastro.2007.08.079 1:CAS:528:DC%2BD2sXhsVGqtr%2FL 17983801 (Pubitemid 350047463)
    • (2007) Gastroenterology , vol.133 , Issue.5 , pp. 1445-1451
    • Lampertico, P.1    Vigano, M.2    Manenti, E.3    Iavarone, M.4    Sablon, E.5    Colombo, M.6
  • 50
    • 61849132825 scopus 로고    scopus 로고
    • On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: Now and future
    • 1:CAS:528:DC%2BD1MXktVertbc%3D 19320233
    • Y.F. Liaw 2009 On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future Antivir Ther 14 13 22 1:CAS:528:DC%2BD1MXktVertbc%3D 19320233
    • (2009) Antivir Ther , vol.14 , pp. 13-22
    • Liaw, Y.F.1
  • 51
    • 33644882231 scopus 로고    scopus 로고
    • Treatment with Peg-interferon α-2b for HBeAg-positive chronic hepatitis B: HBsAg loss is associated with HBV genotype
    • DOI 10.1111/j.1572-0241.2006.00418.x
    • H.J. Flink B.E. Hansen E.J. Heathcote, et al. 2006 Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudine Am J Gastroenterol 101 2523 2529 10.1111/j.1572-0241. 2006.00418.x 1:CAS:528:DC%2BD28XhtlelsrbI 17029610 (Pubitemid 43381671)
    • (2006) American Journal of Gastroenterology , vol.101 , Issue.2 , pp. 297-303
    • Flink, H.J.1    Van Zonneveld, M.2    Hansen, B.E.3    De Man, R.A.4    Schalm, S.W.5    Janssen, H.L.A.6
  • 52
    • 58949085306 scopus 로고    scopus 로고
    • Management of patients with chronic hepatitis B and cirrhosis
    • Y.F. Liaw 2007 Management of patients with chronic hepatitis B and cirrhosis Curr Hepatitis Rep 6 161 165
    • (2007) Curr Hepatitis Rep , vol.6 , pp. 161-165
    • Liaw, Y.F.1
  • 53
    • 38049087457 scopus 로고    scopus 로고
    • Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease
    • 1:CAS:528:DC%2BD1cXhtVGqsLs%3D 18240869
    • M.F. Yuen W.K. Seto D.H.F. Chow, et al. 2007 Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease Antivir Ther 12 1295 1303 1:CAS:528:DC%2BD1cXhtVGqsLs%3D 18240869
    • (2007) Antivir Ther , vol.12 , pp. 1295-1303
    • Yuen, M.F.1    Seto, W.K.2    Chow, D.H.F.3
  • 55
    • 0142244873 scopus 로고    scopus 로고
    • Determinants for Sustained HBeAg Response to Lamivudine Therapy
    • DOI 10.1053/jhep.2003.50458
    • R.N. Chien C.T. Yeh S.L. Tsai, et al. 2003 The determinants for sustained HBeAg response to lamivudine therapy Hepatology 38 1267 1273 10.1053/jhep.2003.50458 1:CAS:528:DC%2BD3sXpsVOnt7w%3D 14578866 (Pubitemid 37314836)
    • (2003) Hepatology , vol.38 , Issue.5 , pp. 1267-1273
    • Chien, R.-N.1    Yeh, C.-T.2    Tsai, S.-L.3    Chu, C.-M.4    Liaw, Y.-F.5

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.